• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸膜间皮瘤和肺腺癌中凝血调节蛋白的表达

Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.

作者信息

Collins C L, Ordonez N G, Schaefer R, Cook C D, Xie S S, Granger J, Hsu P L, Fink L, Hsu S M

机构信息

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock.

出版信息

Am J Pathol. 1992 Oct;141(4):827-33.

PMID:1357974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1886631/
Abstract

Thrombomodulin (TM) is a glycoprotein of molecular weight 75,000 kd that is normally present in restricted numbers of cells, including endothelial and mesothelial cells. In this study, the authors tested the possibility of using anti-TM to facilitate the diagnosis of mesothelioma. All of the 31 mesotheliomas and the two mesothelioma cell lines (MS-1 and MS-2) tested were stained positively with anti-TM. The specificity of anti-TM staining in mesothelioma cells was further confirmed by in situ hybridization of MS-1 cells with a TM-specific probe. The expression of TM in MS-1 cells was increased markedly when these cells were induced by 12-0-tetradecanyl phorbol 13-acetate (TPA) to differentiate. The expression of TM in mesothelioma cells, however, did not correlate with any particular phase of the cell cycle. In an attempt to differentiate pleural mesothelioma from pulmonary adenocarcinoma, the authors compared the expression of TM, carcinoembryonic antigen (CEA), and Leu M1 in these two types of tumors. Only four of 48 (8%) pulmonary adenocarcinomas were stained positively by antibodies to TM. Therefore, immunohistochemical staining with antibodies to TM yielded 100% sensitivity and 92% specificity for diagnosis of mesothelioma. All of the mesotheliomas stained negatively for CEA and Leu M1, except for one, which showed minimal focal positivity for Leu M1. In contrast, 79% and 60% of adenocarcinomas stained positively for CEA and Leu M1, respectively. These findings suggest that immunocytochemical staining with anti-TM should be added to the battery of tests to increase the diagnostic sensitivity and specificity for differentiating mesothelioma from pulmonary adenocarcinoma.

摘要

血栓调节蛋白(TM)是一种分子量为75,000kd的糖蛋白,通常仅存在于有限数量的细胞中,包括内皮细胞和间皮细胞。在本研究中,作者测试了使用抗TM抗体来辅助诊断间皮瘤的可能性。所检测的31例间皮瘤以及两种间皮瘤细胞系(MS-1和MS-2)均被抗TM抗体阳性染色。通过用TM特异性探针与MS-1细胞进行原位杂交,进一步证实了抗TM染色在间皮瘤细胞中的特异性。当MS-1细胞被12-0-十四烷酰佛波醇-13-乙酸酯(TPA)诱导分化时,TM在这些细胞中的表达显著增加。然而,间皮瘤细胞中TM的表达与细胞周期的任何特定阶段均无关联。为了鉴别胸膜间皮瘤与肺腺癌,作者比较了这两种肿瘤中TM、癌胚抗原(CEA)和Leu M1的表达。48例肺腺癌中仅有4例(8%)被抗TM抗体阳性染色。因此,用抗TM抗体进行免疫组化染色对间皮瘤诊断的敏感性为100%,特异性为92%。除1例间皮瘤对Leu M1显示极轻微局灶性阳性外,所有间皮瘤对CEA和Leu M1染色均为阴性。相比之下,分别有79%和60%的腺癌对CEA和Leu M1染色呈阳性。这些发现表明,应将抗TM免疫细胞化学染色添加到检测项目中,以提高鉴别间皮瘤与肺腺癌的诊断敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d20/1886631/59c6322f01d5/amjpathol00082-0069-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d20/1886631/59c6322f01d5/amjpathol00082-0069-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d20/1886631/59c6322f01d5/amjpathol00082-0069-a.jpg

相似文献

1
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.恶性胸膜间皮瘤和肺腺癌中凝血调节蛋白的表达
Am J Pathol. 1992 Oct;141(4):827-33.
2
Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.钙视网膜蛋白、血栓调节蛋白、癌胚抗原和CD15:用于鉴别胸膜上皮性间皮瘤与周围型肺腺癌的一组有用的免疫组化标志物。
Hum Pathol. 2001 May;32(5):529-36. doi: 10.1053/hupa.2001.24329.
3
Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.恶性间皮瘤:免疫组织化学和DNA倍体分析作为鉴别胸膜和腹膜积液中间皮瘤与良性反应性间皮细胞增生及腺癌的方法。
Arch Pathol Lab Med. 1996 Oct;120(10):959-66.
4
Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.七种单克隆抗体用于鉴别胸膜间皮瘤与肺腺癌的免疫组织化学评估
Cancer. 1991 Feb 1;67(3):655-62. doi: 10.1002/1097-0142(19910201)67:3<655::aid-cncr2820670322>3.0.co;2-j.
5
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.恶性间皮瘤和肺腺癌的抗原表型。一项免疫组织学分析证明了Leu M1抗原的价值。
Am J Pathol. 1986 May;123(2):212-9.
6
The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.间皮瘤的免疫组化诊断。间皮瘤与肺腺癌的鉴别。
Am J Surg Pathol. 1989 Apr;13(4):276-91.
7
Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.免疫组织化学在恶性间皮瘤与肺腺癌鉴别诊断中的应用:对新型抗体的批判性评估
J Clin Pathol. 2002 Sep;55(9):662-8. doi: 10.1136/jcp.55.9.662.
8
The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.间皮瘤的免疫组织化学诊断:上皮样间皮瘤与肺腺癌的对比研究
Am J Surg Pathol. 2003 Aug;27(8):1031-51. doi: 10.1097/00000478-200308000-00001.
9
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.区分恶性胸膜间皮瘤与肺腺癌的多标记免疫组化表型
Hum Pathol. 1993 Apr;24(4):347-54. doi: 10.1016/0046-8177(93)90080-z.
10
Utility of a CEA, CD15, calretinin, and CK5/6 panel for distinguishing between mesotheliomas and pulmonary adenocarcinomas in clinical practice.CEA、CD15、钙视网膜蛋白和 CK5/6 联合检测在临床实践中鉴别间皮瘤和肺腺癌的价值。
Am J Surg Pathol. 2012 Oct;36(10):1503-8. doi: 10.1097/PAS.0b013e31825d5371.

引用本文的文献

1
Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation.异基因干细胞移植后的内皮功能障碍综合征
Cancers (Basel). 2023 Jan 22;15(3):680. doi: 10.3390/cancers15030680.
2
Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.循环血栓调节蛋白:释放机制、检测方法以及在疾病和医疗程序中的水平
TH Open. 2022 Jul 11;6(3):e194-e212. doi: 10.1055/a-1801-2055. eCollection 2022 Jul.
3
Risk factors for disseminated intravascular coagulation in patients with lung cancer.

本文引用的文献

1
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.凝血酶催化蛋白C活化的膜结合辅因子的分离。
J Biol Chem. 1982 Jan 25;257(2):859-64.
2
Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma.免疫组织化学确诊的恶性上皮性间皮瘤病例中倍性的流式细胞术分析
Am J Clin Pathol. 1988 Sep;90(3):240-3. doi: 10.1093/ajcp/90.3.240.
3
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.
肺癌患者弥散性血管内凝血的危险因素。
Thorac Cancer. 2018 Aug;9(8):931-938. doi: 10.1111/1759-7714.12766. Epub 2018 May 31.
4
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.体外患者来源的 3D 间皮瘤肿瘤类器官促进以患者为中心的治疗筛选。
Sci Rep. 2018 Feb 13;8(1):2886. doi: 10.1038/s41598-018-21200-8.
5
Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer.重组人血栓调节蛋白对肺癌患者弥散性血管内凝血的影响
Intern Med. 2017;56(14):1799-1806. doi: 10.2169/internalmedicine.56.7143. Epub 2017 Jul 15.
6
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤诊断与治疗指南。
J Thorac Dis. 2013 Dec;5(6):E254-307. doi: 10.3978/j.issn.2072-1439.2013.11.28.
7
Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.从人恶性间皮瘤中纯化建立永久细胞系:形态学特征、新标志物表达及核型分析
Histochem Cell Biol. 2004 Sep;122(3):249-60. doi: 10.1007/s00418-004-0701-1. Epub 2004 Sep 15.
8
Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.免疫组织化学在恶性间皮瘤与肺腺癌鉴别诊断中的应用:对新型抗体的批判性评估
J Clin Pathol. 2002 Sep;55(9):662-8. doi: 10.1136/jcp.55.9.662.
9
HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.HBME-1和抗凝血酶调节蛋白在胸膜恶性间皮瘤鉴别诊断中的应用
J Clin Pathol. 1997 Oct;50(10):859-62. doi: 10.1136/jcp.50.10.859.
10
Expression and localization of thrombomodulin in preneoplastic bronchial lesions and in lung cancer.血栓调节蛋白在癌前支气管病变及肺癌中的表达与定位
Virchows Arch. 1997 Mar;430(3):209-12. doi: 10.1007/BF01324803.
血栓调节蛋白存在于动脉、静脉、毛细血管和淋巴管的内皮细胞上,以及人胎盘的合体滋养层细胞上。
J Cell Biol. 1985 Aug;101(2):363-71. doi: 10.1083/jcb.101.2.363.
4
Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1.肺腺癌与间皮瘤的鉴别诊断。高碘酸-希夫反应、单克隆抗体B72.3和白细胞共同抗原M1。
Am J Pathol. 1988 Oct;133(1):30-8.
5
Immunohistochemical localization of thrombomodulin in chorionic diseases of the uterus and choriocarcinoma of the stomach. A comparative study with the distribution of human chorionic gonadotropin.血栓调节蛋白在子宫绒毛膜疾病及胃绒毛膜癌中的免疫组织化学定位。与人绒毛膜促性腺激素分布的比较研究。
Cancer. 1988 Aug 1;62(3):569-76. doi: 10.1002/1097-0142(19880801)62:3<569::aid-cncr2820620322>3.0.co;2-t.
6
Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene.人血栓调节蛋白:基因的完整cDNA序列及染色体定位
Biochemistry. 1987 Jul 14;26(14):4350-7. doi: 10.1021/bi00388a025.
7
Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation.人血栓调节蛋白的结构与表达,一种内皮细胞上的凝血酶受体,作为蛋白C活化的辅因子。
EMBO J. 1987 Jul;6(7):1891-7. doi: 10.1002/j.1460-2075.1987.tb02448.x.
8
The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.间皮瘤的免疫组化诊断。间皮瘤与肺腺癌的鉴别。
Am J Surg Pathol. 1989 Apr;13(4):276-91.
9
Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody.关于抗间皮细胞抗体结合情况的恶性间皮瘤组织学诊断验证
Cancer. 1989 Apr 1;63(7):1331-6. doi: 10.1002/1097-0142(19890401)63:7<1331::aid-cncr2820630718>3.0.co;2-3.
10
Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.肉瘤样间皮瘤与其他梭形细胞肿瘤的免疫组化鉴别
Am J Clin Pathol. 1989 Nov;92(5):566-71. doi: 10.1093/ajcp/92.5.566.